RESUMEN
Staphylococcus aureus is the most common bacteria causing purulent skin and soft tissue infections. Many disease-causing S aureus strains are methicillin resistant; thus, empiric therapy should be given to cover methicillin-resistant S aureus. Bacterial wound cultures are important for characterizing local susceptibility patterns. Definitive antibiotic therapy is warranted, although there are no compelling data demonstrating superiority of any one antibiotic over another. Antibiotic choice is predicated by the infection severity, local susceptibility patterns, and drug-related safety, tolerability, and cost. Response to therapy is expected within the first days; 5 to 7 days of therapy is typically adequate to achieve cure.
Asunto(s)
Infecciones de los Tejidos Blandos/diagnóstico , Infecciones de los Tejidos Blandos/terapia , Infecciones Cutáneas Estafilocócicas/diagnóstico , Infecciones Cutáneas Estafilocócicas/terapia , Staphylococcus aureus/patogenicidad , Absceso/microbiología , Absceso/terapia , Algoritmos , Antibacterianos/uso terapéutico , Celulitis (Flemón)/microbiología , Celulitis (Flemón)/terapia , Drenaje/métodos , Humanos , Impétigo/microbiología , Impétigo/terapia , Resistencia a la Meticilina , Staphylococcus aureus Resistente a Meticilina/patogenicidad , Factores de Riesgo , Infecciones de los Tejidos Blandos/microbiología , Infecciones Cutáneas Estafilocócicas/microbiologíaRESUMEN
Impetigo herpetiformis is a rare variant of generalized pustular psoriasis that occurs during pregnancy or is triggered by pregnancy, often in association with hypocalcemia. This condition is associated with increased maternal and fetal morbidity and mortality. We report a 29-year-old pregnant woman who presented to hospital at the gestational age of 20 weeks with widespread erythema covered with pustules that coalesced to form lakes of pus. She did not respond to corticosteroids, immunosuppressants, or phototherapy. Finally, intra-amniotic injection of ethacridine lactate was administered to terminate the pregnancy, and the patient showed complete recovery in 3 months. Insight from this case report may facilitate optimal management of this relatively rare entity.
Asunto(s)
Impétigo/complicaciones , Impétigo/mortalidad , Impétigo/terapia , Aborto Inducido/métodos , Corticoesteroides , Adulto , China , Etacridina/farmacología , Femenino , Humanos , Inmunosupresores , Embarazo , Psoriasis/complicacionesRESUMEN
Many pediatric skin conditions can be safely monitored with minimal intervention, but certain skin conditions are emergent and require immediate attention and proper assessment of the neonate, infant, or child. We review the following pediatric dermatology emergencies so that clinicians can detect and accurately diagnose these conditions to avoid delayed treatment and considerable morbidity and mortality if missed: staphylococcal scalded skin syndrome (SSSS), impetigo, eczema herpeticum (EH), Langerhans cell histiocytosis (LCH), infantile hemangioma (IH), and IgA vasculitis.
Asunto(s)
Enfermedades de la Piel/diagnóstico , Niño , Diagnóstico Diferencial , Urgencias Médicas , Hemangioma Capilar/diagnóstico , Hemangioma Capilar/terapia , Histiocitosis de Células de Langerhans/diagnóstico , Histiocitosis de Células de Langerhans/terapia , Humanos , Vasculitis por IgA/diagnóstico , Vasculitis por IgA/terapia , Impétigo/diagnóstico , Impétigo/terapia , Erupción Variceliforme de Kaposi/diagnóstico , Erupción Variceliforme de Kaposi/terapia , Síndromes Neoplásicos Hereditarios/diagnóstico , Síndromes Neoplásicos Hereditarios/terapia , Enfermedades de la Piel/terapia , Síndrome Estafilocócico de la Piel Escaldada/diagnóstico , Síndrome Estafilocócico de la Piel Escaldada/terapia , Síndrome de Stevens-Johnson/diagnóstico , Síndrome de Stevens-Johnson/terapiaAsunto(s)
Impétigo , Síndrome Estafilocócico de la Piel Escaldada , Niño , Preescolar , Humanos , Impétigo/diagnóstico , Impétigo/etiología , Impétigo/patología , Impétigo/terapia , Lactante , Pediatría , Síndrome Estafilocócico de la Piel Escaldada/diagnóstico , Síndrome Estafilocócico de la Piel Escaldada/etiología , Síndrome Estafilocócico de la Piel Escaldada/patología , Síndrome Estafilocócico de la Piel Escaldada/terapiaAsunto(s)
Eliminación de Componentes Sanguíneos , Proteínas Adaptadoras de Señalización CARD/genética , Guanilato Ciclasa/genética , Impétigo/genética , Proteínas de la Membrana/genética , Complicaciones Infecciosas del Embarazo/genética , Piel/patología , Adulto , Femenino , Humanos , Impétigo/patología , Impétigo/terapia , Embarazo , Complicaciones Infecciosas del Embarazo/patología , Complicaciones Infecciosas del Embarazo/terapiaRESUMEN
INTRODUCTION: Skin is important in Australian Aboriginal culture informing kinship and identity. In many remote Aboriginal communities, scabies and impetigo are very common. Untreated skin infections are painful, itchy and frequently go untreated due to under-recognition and lack of awareness of their potential serious complications. We hypothesise that the skin infection burden in remote Aboriginal communities can be reduced by implementing streamlined training and treatment pathways integrated with environmental health and health promotion activities, tested in the See, Treat, Prevent (SToP skin sores and scabies) trial. METHODS AND ANALYSIS: SToP will evaluate a skin control programme using a stepped-wedge, cluster randomised trial design with three intervention components (the 'SToP activities'): (1) seeing skin infections (development of training resources implemented within a community dermatology model); (2) treating skin infections (employing the latest evidence for impetigo, and scabies treatment); and (3) preventing skin infections (embedded, culturally informed health promotion and environmental health activities). Four community clusters in the remote Kimberley region of Western Australia will participate. Following baseline data collection, two clusters will be randomly allocated to the SToP activities. At 12 months, the remaining two clusters will transition to the SToP activities. The primary outcome is the diagnosis of impetigo in children (5-9 years) at school-based surveillance. Secondary outcome measures include scabies diagnosis, other child health indicators, resistance to cotrimoxazole in circulating pathogenic bacteria, determining the economic burden of skin disease and evaluating the cost effectiveness of SToP activities. ETHICS AND DISSEMINATION: This study protocol was approved by the health ethics review committees at the Child and Adolescent Health Service (Approval number RGS0000000584), the Western Australian Aboriginal Health Ethics Committee (Reference number: 819) and the University of Western Australia (Reference RA/4/20/4123). Study findings will be shared with community members, academic and medical communities via publications and presentations, and in reports to funders. Authorship for all publications based on this study will be determined in line with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals published by the International Committee of Medical Journal Editors. Sharing results with organisations and communities who contributed to the study is paramount. The results of the SToP trial will be shared with participants in a suitable format, such as a single summary page provided to participants or presentations to communities, the Kimberly Aboriginal Health Planning Forum Research Subcommittee and other stakeholders as appropriate and as requested. Communication and dissemination will require ongoing consultation with Aboriginal communities to determine appropriate formats. TRIAL REGISTRATION NUMBER: ACTRN12618000520235.
Asunto(s)
Salud Ambiental/métodos , Promoción de la Salud/métodos , Servicios de Salud del Indígena , Impétigo , Escabiosis , Servicios de Salud Escolar , Australia/epidemiología , Niño , Costo de Enfermedad , Análisis Costo-Beneficio , Dermatología/educación , Dermatología/métodos , Femenino , Humanos , Impétigo/economía , Impétigo/epidemiología , Impétigo/terapia , Masculino , Ensayos Clínicos Pragmáticos como Asunto , Escabiosis/economía , Escabiosis/epidemiología , Escabiosis/terapia , Enseñanza/organización & administración , Australia Occidental/epidemiologíaAsunto(s)
Adalimumab/administración & dosificación , Dermatitis Herpetiforme/terapia , Impétigo/terapia , Complicaciones del Embarazo/terapia , Brote de los Síntomas , Adulto , Dermatitis Herpetiforme/diagnóstico , Dermatitis Herpetiforme/patología , Esquema de Medicación , Femenino , Humanos , Impétigo/diagnóstico , Impétigo/patología , Inyecciones Subcutáneas , Procedimientos de Reducción del Leucocitos , Periodo Posparto , Embarazo , Complicaciones del Embarazo/diagnóstico , Complicaciones del Embarazo/patología , Resultado del TratamientoRESUMEN
We conducted a systematic review of the treatment, prevention and public health control of skin infections including impetigo, scabies, crusted scabies and tinea in resource-limited settings where skin infections are endemic. The aim is to inform strategies, guidelines and research to improve skin health in populations that are inequitably affected by infections of the skin and the downstream consequences of these. The systematic review is reported according to the PRISMA statement. From 1759 titles identified, 81 full text studies were reviewed and key findings outlined for impetigo, scabies, crusted scabies and tinea. Improvements in primary care and public health management of skin infections will have broad and lasting impacts on overall quality of life including reductions in morbidity and mortality from sepsis, skeletal infections, kidney and heart disease.
Nous avons effectué une analyse systématique du traitement, de la prévention et du contrôle de santé publique des infections cutanées comprenant l'impétigo, la gale, la gale en croûte et la teigne, dans des cadres à ressources limitées où les infections cutanées sont endémiques. Le but étant d'informer les stratégies, les directives et la recherche pour améliorer la santé de la peau dans les populations qui sont touchées de manière inéquitable par les infections cutanées et leurs conséquences plus tard. La revue systématique est rapportée selon la déclaration PRISMA. Sur 1759 titres recensés, 81 études en texte intégral ont été passées en revue et les principaux résultats rapportés concernant l'impétigo, la gale, la gale en croûte et la teigne. Les améliorations apportées dans la prise en charge des infections de la peau dans les soins de santé primaires et les soins de santé publique auront des répercussions vastes et durables sur la qualité de vie en général, notamment une réduction de la morbidité et de la mortalité dues au sepsis, aux infections du squelette, aux maladies du rein et du cÅur.
Asunto(s)
Dermatomicosis/terapia , Impétigo/terapia , Escabiosis/terapia , Dermatomicosis/prevención & control , Humanos , Impétigo/prevención & control , Salud Pública , Escabiosis/prevención & controlAsunto(s)
Eliminación de Componentes Sanguíneos/métodos , Dermatitis Herpetiforme/terapia , Granulocitos/inmunología , Monocitos/inmunología , Complicaciones del Embarazo/terapia , Adsorción , Adulto , Cesárea , Dermatitis Herpetiforme/complicaciones , Dermatitis Herpetiforme/inmunología , Femenino , Glucocorticoides/uso terapéutico , Humanos , Impétigo/complicaciones , Impétigo/inmunología , Impétigo/terapia , Prednisolona/uso terapéutico , Embarazo , Complicaciones del Embarazo/inmunologíaAsunto(s)
Dermatitis Herpetiforme/terapia , Retardo del Crecimiento Fetal/terapia , Granulocitos/inmunología , Impétigo/terapia , Leucaféresis/métodos , Monocitos/inmunología , Piel/inmunología , Biopsia , Dermatitis Herpetiforme/sangre , Dermatitis Herpetiforme/diagnóstico , Femenino , Retardo del Crecimiento Fetal/sangre , Retardo del Crecimiento Fetal/diagnóstico , Retardo del Crecimiento Fetal/inmunología , Humanos , Impétigo/sangre , Impétigo/diagnóstico , Impétigo/inmunología , Embarazo , Factores de Riesgo , Piel/patología , Resultado del TratamientoRESUMEN
Impetigo and scabies both present different challenges in resource-limited compared with industrialised settings. Severe complications of these skin infections are common in resource-limited settings, where the burden of disease is highest. The microbiology, risk factors for disease, diagnostic approaches and availability and suitability of therapies also vary according to setting. Taking this into account we aim to summarise recent data on the epidemiology of impetigo and scabies and describe the current evidence around approaches to individual and community based treatment.
Asunto(s)
Servicios de Salud Comunitaria , Costo de Enfermedad , Impétigo/terapia , Escabiosis/terapia , Piel/microbiología , Niño , Preescolar , Recursos en Salud , Humanos , Impétigo/epidemiología , Impétigo/microbiología , Piodermia/microbiología , Escabiosis/epidemiología , Escabiosis/parasitología , Piel/fisiopatologíaRESUMEN
BACKGROUND: Skin infections account for a high disease burden in indigenous children living in northern Australia. Although the relationship between impetigo and scabies is recognized, the prevalence of scabies in children with impetigo is not well reported. We report the prevalence, demographics and treatment success outcomes of impetigo and scabies coinfection in indigenous children who were participants in a randomized controlled trial of impetigo treatment conducted in remote communities of the Northern Territory, Australia. METHODS: Of 1715 screening episodes for impetigo, 508 children were randomized to receive intramuscular benzathine benzylpenicillin (BPG), twice daily co-trimoxazole (SXT) for 3 days (4 mg/kg trimethoprim plus 20 mg/kg sulfamethoxazole per dose) or once daily SXT for 5 days (8 mg/kg trimethoprim plus 40 mg/kg sulfamethoxazole per dose). A clinical diagnosis of scabies; tinea of the skin, scalp or nail; and head lice was made on all children. Scabies presence was not confirmed using diagnostic scrapings. In a post-hoc analysis, we determined whether coinfection with scabies had an impact on treatment success for impetigo. RESULTS: Of children randomized to receive treatment for impetigo, 84 of 508 (16.5%) had scabies. The presence of scabies ranged from 14.3% to 20.0% in the 3 treatment groups. Treatment success for impetigo with and without scabies coinfection, independent of the treatment groups, was 75.9% and 86.6%, respectively, absolute difference 10.7% [95% confidence interval (CI): +1% to +21%]. Treatment success for impetigo with and without scabies coinfection in the BPG group was 69.6% and 88.0%, respectively, absolute difference 18.4% (95% CI: -1% to +38%). In the pooled SXT groups, the treatment success for impetigo with and without scabies coinfection was 78.6% and 86.0%, respectively, with absolute difference 7.4% (95% CI: -4% to +18%). Treatment success in the pooled SXT group with scabies (78.6%) was higher than in the BPG group (69.6%) with scabies, absolute difference 9.0% (95% CI: +0.1% to +18%). Prediction of treatment success for impetigo is dependent on the presence or absence of scabies and for scabies coinfected impetigo it was higher in the group treated with SXT. CONCLUSIONS: The burden of scabies in an impetigo trial for Indigenous children was high. Treatment success for scabies coinfection was lower than for impetigo overall, with a higher success seen in the SXT group than the BPG group.
Asunto(s)
Coinfección , Impétigo/complicaciones , Impétigo/epidemiología , Escabiosis/complicaciones , Escabiosis/epidemiología , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéutico , Niño , Preescolar , Toma de Decisiones Clínicas , Femenino , Humanos , Impétigo/terapia , Masculino , Northern Territory/epidemiología , Prevalencia , Resultado del TratamientoRESUMEN
PURPOSE: Neutrophil-specific granule deficiency (SGD) is a rare, congenital disorder characterized by atypical neutrophil structure and function that results in frequent and severe bacterial infections. However, the clinical course of patients with SGD have not been described in detail because of the scarcity of the disease. We present the clinical course of an adult patient with SGD and propose a method for making an early diagnosis of SGD. PATIENT AND METHODS: A32-year-old Japanese woman with SGD had a small impetigo lesion on her face and experienced the rapid spread of a facial abscess to a pulmonary abscess via the blood stream. We also analyzed the expression of neutrophil granule proteins in our patient compared with a healthy control by flow cytometry. RESULTS: We confirmed defects of several neutrophil granule proteins in our patient by flow cytometry. CONCLUSION: Severe bacterial infections sometimes occur and spread rapidly in SGD. Detection of neutrophil granules by flow cytometry is useful for a rapid diagnosis and a screening of SGD.
Asunto(s)
Síndromes de Inmunodeficiencia/diagnóstico , Impétigo/diagnóstico , Absceso Pulmonar/diagnóstico , Neutrófilos/metabolismo , Vesículas Secretoras/metabolismo , Proteínas de Fase Aguda/metabolismo , Adulto , Profilaxis Antibiótica , Péptidos Catiónicos Antimicrobianos/metabolismo , Proteínas Sanguíneas/metabolismo , Proteínas Potenciadoras de Unión a CCAAT/genética , Desbridamiento , Defensinas/metabolismo , Femenino , Citometría de Flujo , Humanos , Síndromes de Inmunodeficiencia/genética , Síndromes de Inmunodeficiencia/terapia , Impétigo/genética , Impétigo/terapia , Japón , Lactoferrina/metabolismo , Lipocalina 2 , Lipocalinas/metabolismo , Absceso Pulmonar/genética , Absceso Pulmonar/terapia , Mutación/genética , Neutrófilos/patología , Peroxidasa/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , CatelicidinasAsunto(s)
Fascitis Necrotizante/patología , Foliculitis/patología , Impétigo/patología , Intertrigo/patología , Paroniquia/patología , Tiña del Pie/patología , Fascitis Necrotizante/etiología , Fascitis Necrotizante/terapia , Foliculitis/etiología , Foliculitis/terapia , Humanos , Impétigo/etiología , Impétigo/terapia , Intertrigo/etiología , Intertrigo/terapia , Paroniquia/etiología , Paroniquia/terapia , Tiña del Pie/etiología , Tiña del Pie/terapiaRESUMEN
Skin and soft tissue infections are a common reason for consultation in primary health care centers. Data from the local epidemiology of these infections are rare, but Staphylococcus aureus and Streptococcus pyogenes are known to be the major etiologic agents. The appearance in recent years of community-originated strains of methicillin-resistant S. aureus and erythromycin-resistant pyogenes raises controversy in the choice of initial empirical treatment. This national consensus is for pediatricians, dermatologists, infectiologists and other health professionals. It is about clinical management, especially the diagnosis and treatment of community-originated skin and soft tissue infections in immunocompetent patients under the age of 19.
Asunto(s)
Enfermedades Cutáneas Infecciosas/diagnóstico , Enfermedades Cutáneas Infecciosas/terapia , Infecciones de los Tejidos Blandos/diagnóstico , Infecciones de los Tejidos Blandos/terapia , Niño , Erisipela/diagnóstico , Erisipela/terapia , Foliculitis/diagnóstico , Foliculitis/terapia , Forunculosis/diagnóstico , Forunculosis/terapia , Humanos , Impétigo/diagnóstico , Impétigo/terapiaRESUMEN
Las infecciones de piel y partes blandas son una causa frecuente de consulta en los centros de atención primaria de la salud. Los datos de la epidemiología local de estas infecciones son escasos; el Staphylococcus aureus y el Streptococcus pyogenes son los principales agentes etiológicos. La emergencia, en los últimos años, de cepas de S. aureus meticilino resistentes provenientes de la comunidad y S. pyogenes resistentes a eritromicina plantea controversias en la elección del tratamiento empírico inicial. Este consenso nacional está dirigido a médicos pediatras, de familia, dermatólogos, infectólogos y otros profesionales de la salud. Trata el manejo clínico, especialmente el diagnóstico y tratamiento, de las infecciones de piel y partes blandas de origen bacteriano provenientes de la comunidad en pacientes inmunocompetentes menores de 19 años de edad.
Skin and soft tissue infections are a common reason for consultation in primary health care centers. Data from the local epidemiology of these infections are rare, but Staphylococcus aureus and Streptococcus pyogenes are known to be the major etiologic agents. The appearance in recent years of community-originated strains of methicillin-resistant S. aureus and erythromycin-resistant pyogenes raises controversy in the choice of initial empirical treatment. This national consensus is for pediatricians, dermatologists, infectologists and other health professionals. It is about clinical management, especially the diagnosis and treatment of commu-nity-originated skin and soft tissue infections in immunocompetent patients under the age of 19.
Asunto(s)
Humanos , Recién Nacido , Lactante , Preescolar , Niño , Adolescente , Enfermedades Cutáneas Infecciosas/diagnóstico , Enfermedades Cutáneas Infecciosas/terapia , Infecciones de los Tejidos Blandos/diagnóstico , Infecciones de los Tejidos Blandos/terapia , Erisipela/diagnóstico , Erisipela/terapia , Foliculitis/diagnóstico , Foliculitis/terapia , Forunculosis/diagnóstico , Forunculosis/terapia , Impétigo/diagnóstico , Impétigo/terapiaAsunto(s)
Corticoesteroides/administración & dosificación , Inhibidores de la Calcineurina , Dermatitis Atópica/diagnóstico , Dermatitis Atópica/terapia , Fármacos Dermatológicos/administración & dosificación , Administración Oral , Administración Tópica , Antibacterianos/administración & dosificación , Dermatitis Atópica/prevención & control , Dermatosis Facial/diagnóstico , Dermatosis Facial/prevención & control , Dermatosis Facial/terapia , Humanos , Impétigo/diagnóstico , Impétigo/prevención & control , Impétigo/terapia , Lactante , Recién Nacido , Ensayos Clínicos Controlados Aleatorios como Asunto , Prevención Secundaria , Infecciones Cutáneas Estafilocócicas/diagnóstico , Infecciones Cutáneas Estafilocócicas/terapiaRESUMEN
Vesicobullous and inflammatory diseases produce vulvar erosions that may exhibit nonspecific morphology and represent a diagnostic challenge. An approach to arriving at the correct diagnosis is presented. Most common etiologies are reviewed.